<DOC>
	<DOC>NCT02271854</DOC>
	<brief_summary>This study will assess the analgesic efficacy of DSG 1% compared to placebo in the reduction of the pain associated with DOMS</brief_summary>
	<brief_title>A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness</brief_title>
	<detailed_description />
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Male or female subjects aged 1835 years Not engaged in regular lower extremity fitness activities in the past 6 months prior to screening Willing to refrain from use of ice, heat and massage during the study DOMS score ≥4 Pain at Rest (PAR) and a DOMS score ≥5 Pain on Walking (POW), with moderate or severe on categorical scale Pain medication &amp; corticosteroids prior to randomization Topical analgesic or antiinflammatory treatment over the previous month Body mass index of &gt;32 kg/m2 Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>